[Human insulin vs. analogs. What is the cost of supplementary insulin therapy?]

MMW Fortschr Med. 2006 Nov 9;148(45):42.
[Article in German]
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / economics*
  • Dose-Response Relationship, Drug
  • Drug Costs / statistics & numerical data*
  • Drug Therapy, Combination
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemic Agents / economics*
  • Hypoglycemic Agents / therapeutic use
  • Insulin / administration & dosage
  • Insulin / analogs & derivatives*
  • Insulin / economics*
  • Insulin Aspart
  • Metformin / administration & dosage
  • Metformin / economics

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Metformin
  • Insulin Aspart